Report of the second dementia with Lewy body international workshop: Diagnosis and treatment

Neurology

Volumn 53, Issue 5, 1999, Pages 902-905

  McKeith, I G ^a   Perry, E K ^b   Perry, R H ^b  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Dementia; Diagnosis; Lewy body; Treatment; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; UBIQUITIN;

CLINICAL FEATURE; CLINICAL PRACTICE; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENETIC ANALYSIS; HUMAN; IMMUNOCYTOCHEMISTRY; LEWY BODY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; WORKSHOP;

EID: 0033595485     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.5.902     Document Type: Review

References (34)

1. Papka M, Rubio A, Schiffer RB. A review of Lewy body disease, an emerging concept of cortical dementia. J Neuropsychiatry Clin Neurosci 1998;10:267-279.
2. Perry RH, McKeith IG, Perry EK. Dementia with Lewy bodies. New York: Cambridge University Press, 1996.
3. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
4. Mega MS, Masterman DL, Benson F, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996;47:1403-1409.
5. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999;174:45-51.
6. McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry 1994;165:324-332.
7. Lebert F, Mouly C, Maurage CA, Petit H, Pasquier F. Vascular dementia: a possible misdiagnosis of probable dementia with Lewy bodies. Neurobiol Aging 1998;19(4S):S204. Abstract.
8. Perry RH, Jaros E, Ince P, et al. Dementia with Lewy bodies; histopathological aspects of differential diagnosis. Neurobiol Aging 1998;19(4S):S203. Abstract.
9. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-877.
10. Ballard C, McKeith, Burn D, et al. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurol Scand 1997; 96:366-371.
11. Louis E, Klatka L, Liu Y, Fahn, S. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and Parkinson's disease: do the parkinsonian features differ? Adv Neurol 1996;69:311-314.
12. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 1997;62:243-252.
13. Salmon D, Galasko D. Neuropsychological aspects of Lewy body dementia. In: Perry RH, McKeith IG, Perry EK, eds. Dementia with Lewy bodies. New York: Cambridge University Press, 1996:99-114.
14. Sahgal A, Galloway PG, McKeith IG, Edwardson JA, Lloyd S. A comparative study of attentional deficits in patients with senile dementia of the Alzheimer and Lewy body types. Dementia 1992;3:350-354.
15. Boeve BF, Silber MH, Fernian TJ, et al. REM sleep behavior disorder and degenerative dementia. An association likely reflecting Lewy body disease. Neurology 1998;51:363-370.
16. Ballard CG, Holmes C, McKeith et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and pathological comparative study with AD. Am J Psychiatry 1999; 156:1039-1045.
17. Klatka L, Louis E, Schiffer RB. Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease control groups. Neurology 1996;47:1148-1152.
18. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 1997; 48:126-132.
19. Hansen LA. Tautological tangles in neuropathologic criteria for dementias associated with Lewy bodies. In: Perry RH, McKeith IG, Perry EK, eds. Dementia with Lewy bodies. New York: Cambridge University Press, 1996:204-211.
20. Ball M, Braak H, Coleman P, et al. Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease. Neurobiol Aging 1998;1S:S1-S2.
21. Kosaka K, Iseki E, Odawar T, Yamamoto T. Cerebral type of Lewy body disease. Neuropathology 1996;16:32-35.
22. Samuel W, Alford M, Hofstetter CR, Hansen L. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol 1997;56:499-508.
23. Perry RH, Jaros EB, Irving D, et al. What is the neuropathological basis of dementia associated with Lewy bodies? In: Perry RH, McKeith IG, Perry EK, eds. Dementia with Lewy bodies. New York: Cambridge University Press, 1996:212-223.
24. Spillantini MG, Schmidt ML, Lee VMY, et al. α-Synuclein in Lewy bodies. Nature 1997;388:839-848.
25. Goedert M, Jakes R, Spillantini MG. α-Synuclein in the Lewy body. Neurosci News 1997;1(3):47-52.
26. Saitoh T, Katzman R. Genetic correlations in Lewy body disease. In: Perry RH, McKeith IG, Perry EK, eds. Dementia with Lewy bodies. New York: Cambridge University Press, 1996:336-349.
27. Arai H, Murumatsu T, Higuchi S, Sasaski H, Trojanowski J. Apolipoprotein E gene in Parkinson's disease with or without dementia. Lancet 1994;334:889.
28. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999;52:1153-1158.
29. Barber R, Scheltens P, McKeith IG. A comparison of white matter lesions on MRI in dementia with Lewy bodies, Alzheimer's disease, vascular dementia and normal aging. Neurobiol Aging 1998;19(4S):S206. Abstract.
30. McKeith IG, Galasko D, Wilcock GK, Byrne EJ. Lewy body dementia - diagnosis and treatment. Br J Psychiatry 1995; 167:709-717.
31. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J 1992;305:673-678.
32. Cummings JL, Gorman DG, Schapira J. Physostigmine ameliorates the delusions of Alzheimer's disease. Biol Psychiatry 1993;33:536-541.
33. Hutchinson M, Fazzini E. Cholinesterase inhibition in Parkinson's disease. J Neurol Neurosurg Psychiatry 1996;61:324-325.
34. Shea C, MacKnight C, Rockwood K. Donepezil for treatment of dementia with Lewy bodies: a case series of nine cases. Int Psychogeriatr 1998;10:229-238.